Skip to main content

Table 2 The reproductive outcomes in different phenotypes of PCOS patients

From: Impact of dehydroepiandrosterone sulfate and free androgen index on pregnancy and neonatal outcomes in PCOS patients

 

FAI < 6.4

(n = 679)

FAI > 6.4

(n = 204)

P

DHEAS < 9.5 umol/l

(n = 552)

DHEAS > 9.5 umol/l

(n = 220)

P

Clinical pregnancy rate

50.61(344/679)

41.66(85/204)

0.024

51.27(283/552)

42.73(94/220)

0.039

Multiple pregnancies rate

14.12(42/344)

16.47(14/85)

0.300

11.31(32/283)

11.70(11/94)

1.000

Live birth rates

42.42(288/679)

32.35(66/204)

0.011

42.73(238/552)

32.73(72/220)

0.010

Abnormal pregnancy

3.20(11/344)

2.35(2/85)

0.684

3.18(9/283)

2.13(2/94)

0.738

Early miscarriage rate

10.75(43/344)

13.33(14/85)

0.372

14.13(40/283)

14.90(14/94)

0.866

Late miscarriage rate

3.78(13/344)

5.89(5/85)

0.371

1.77(5/283)

8.51(8/94)

0.004

Pregnancy Complications

21.06(60/288)

21.42(14/66

1.000

28.94(69/238)

37.50(27/72)

0.221

Cumulative pregnancy rate

68.53(344/502)

63.43(85/134)

0.311

70.57(283/401)

56.62(94/166)

0.002

Cumulative live birth rate

57.37(288/502)

49.25(66/134)

0.114

59.35(238/401)

43.37(72/166)

0.0007

  1. PCOS: polycystic ovary syndrome; FAI: free androgen index; DHEAS: dehydroepiandrosterone sulfate. p<0.05 is considered to have significant statistical significance